Food and Drug Administration Categorization Notification

Acute Care Hospital Program, Clinical Laboratory Program, Critical Access Hospital Program

Food and Drug Administration Categorization Notification for McKesson Consult Immunochemical Fecal Occult Blood Test Attention:  Clinical Laboratories, Acute Care Hospitals, Critical Access Hospitals Please share this announcement with the following: Medical Director, Laboratory Services Administrative Director and Managers, Laboratory Services On May 4, 2018, the Food and Drug Administration published notice for “McKesson Consult Immunochemical Fecal Occult Blood…

Read more

HFAP Acute Care Manual 2018 v2 Prepublication

Acute Care Hospital Program

New and Revised Standards CMS recently published new requirements for acute care hospitals for the following: Ligature risks (CMS S&C Memo 18-06) Reducing risks of Legionella (CMS S&C Memo 17-30) Texting (CMS QSO 18-10) HFAP has developed several standards to address these changes and we are providing this update as “pre-publication” information to encourage our…

Read more

CMS QSO (FORMERLY S&C) MEMO #18-14-CLIA

Acute Care Hospital Program, Clinical Laboratory Program, Critical Access Hospital Program

“Clarification Regarding Fine Needle Aspiration (FNA) Specimen Adequacy Assessment, Rapid On-site Evaluation (ROSE) and Workload Limits.” Attention: Clinical Laboratories, Acute Care Hospitals, Critical Access Hospitals Please share this announcement with the following: Medical Director, Laboratory Services Administrative Director and Managers, Laboratory Services This CMS Quality, Safety and Oversight memo was issued on March 16, 2018.…

Read more